Skip to main content

Table 2 Differences of NDO-LID antibodies according to their socioeconomic status and origin region

From: Social and environmental conditions related to Mycobacterium leprae infection in children and adolescents from three leprosy endemic regions of Colombia

Variable

Sample size

Anti-NDO-LID

Anti-NDO-LID IgM

Anti- NDO-LID IgG

N (%)

protein A

      
 

(+)

OR (95% CI)

P-value

(+)

OR (95% CI)

P-value

(+)

OR (95% CI)

P-value

N (%)

N (%)

N (%)

SEC Low-low

42 (51)

15 (36)

10.55 (2.2–52.5)

0.001

18 (43)

6.75 (2–22.4)

0.001

5 (12)

5.3 (0.59–47.2)

0.102

SEC Low or Medium-low

40 (49)

2 (5)

  

4 (10)

  

1 (3)

  

Origin UAChR

18 (22)

12 (67)

3.9 (1.9–8.1) UAChR vs AR

< 0.0001

15 (83)

7.5 (1.98–28.3) UAChR vs AR

< 0.0001

3 (6)

2.5 (1.6–3.7) UAChR vs AR

0.136

Origin CR

43 (52)

4 (9)

  

3 (7)

  

3 (7)

  

Origin AR

21 (26)

1 (5)

5.6 (2.5–12.4) UAChR vs CR

 

4 (19)

11.9 (3.9–36.2) UAChR vs CR

 

0

1.8 (0.7–4.5) UAChR vs CR

 
  1. OR odds ratio, CI confidence interval, (+) positive for the presence of anti-NDO-LID antibodies, SEC socioeconomic status, UAChR Uraba-Antioquia-Choco shared region, CR Caribbean region, AR Andean region, OR odds ratio, CI confidence interval, (+) positive for the presence of anti-NDO-LID antibodies